These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26733540)
21. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. Schmidt B; Davis P; Moddemann D; Ohlsson A; Roberts RS; Saigal S; Solimano A; Vincer M; Wright LL; N Engl J Med; 2001 Jun; 344(26):1966-72. PubMed ID: 11430325 [TBL] [Abstract][Full Text] [Related]
22. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. Cordero L; Nankervis CA; Gardner D; Giannone PJ J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778 [TBL] [Abstract][Full Text] [Related]
23. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. Laughon M; Bose C; Clark R J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985 [TBL] [Abstract][Full Text] [Related]
24. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995 [TBL] [Abstract][Full Text] [Related]
25. Comparison of two neonatal indomethacin protocols: efficacy and outcome for patent ductus arteriosus closure. Rosito G; Sum K; Chorne N J Clin Pharm Ther; 2010 Oct; 35(5):589-92. PubMed ID: 20831682 [TBL] [Abstract][Full Text] [Related]
26. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. Liebowitz M; Clyman RI J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025 [TBL] [Abstract][Full Text] [Related]
28. Do early postnatal body weight changes contribute to neonatal morbidities in the extremely low birth weight infants. Verma R; Shibly S; Fang H; Pollack S J Neonatal Perinatal Med; 2015; 8(2):113-8. PubMed ID: 26410434 [TBL] [Abstract][Full Text] [Related]
29. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. Supapannachart S; Limrungsikul A; Khowsathit P J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of prophylactic indomethacin in very-low-birth-weight infants. Moya MP; Goldberg RN Ann Pharmacother; 2002 Feb; 36(2):218-24. PubMed ID: 11847937 [TBL] [Abstract][Full Text] [Related]
31. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS; J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954 [TBL] [Abstract][Full Text] [Related]
32. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. Couser RJ; Ferrara TB; Wright GB; Cabalka AK; Schilling CG; Hoekstra RE; Payne NR J Pediatr; 1996 May; 128(5 Pt 1):631-7. PubMed ID: 8627434 [TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus. Gulack BC; Laughon MM; Clark RH; Sankar MN; Hornik CP; Smith PB Early Hum Dev; 2015 Dec; 91(12):725-9. PubMed ID: 26386610 [TBL] [Abstract][Full Text] [Related]
34. A Comparison of Early Ibuprofen and Indomethacin Administration to Prevent Intraventricular Hemorrhage Among Preterm Infants. Kalani M; Shariat M; Khalesi N; Farahani Z; Ahmadi S Acta Med Iran; 2016 Dec; 54(12):788-792. PubMed ID: 28120591 [TBL] [Abstract][Full Text] [Related]
35. Effect of Prophylactic Indomethacin in Extremely Low Birth Weight Infants Based on the Predicted Risk of Severe Intraventricular Hemorrhage. Foglia EE; Roberts RS; Stoller JZ; Davis PG; Haslam R; Schmidt B; Neonatology; 2018; 113(2):183-186. PubMed ID: 29258076 [TBL] [Abstract][Full Text] [Related]
36. Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight? Robie DK; Waltrip T; Garcia-Prats JA; Pokorny WJ; Jaksic T J Pediatr Surg; 1996 Aug; 31(8):1134-7. PubMed ID: 8863249 [TBL] [Abstract][Full Text] [Related]
37. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681 [TBL] [Abstract][Full Text] [Related]
38. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Ment LR; Oh W; Ehrenkranz RA; Philip AG; Vohr B; Allan W; Duncan CC; Scott DT; Taylor KJ; Katz KH Pediatrics; 1994 Apr; 93(4):543-50. PubMed ID: 8134206 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic closure of the ductus arteriosus: benefits and limitations. Mercanti I; Boubred F; Simeoni U J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358 [TBL] [Abstract][Full Text] [Related]
40. Prophylactic Interventions in Neonatology: How Do They Fare in Real Life? Rolnitsky A; Lee SK; Piedbouf B; Harrison A; Shah PS; Am J Perinatol; 2015 Oct; 32(12):1098-104. PubMed ID: 26171598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]